王翠微, 刘庆涛. 肺鳞癌常规分割配合立体定向放射治疗疗效观察[J]. 中国肿瘤临床, 2004, 31(17): 971-792988.
引用本文: 王翠微, 刘庆涛. 肺鳞癌常规分割配合立体定向放射治疗疗效观察[J]. 中国肿瘤临床, 2004, 31(17): 971-792988.
Wang Cui-wei, Liu Qingtao. Observation on the Effect of Routine Radiotherapy Combining with the Stereotatic Radiotherapy in Treatment of Squamous Cell Cancer of Lung[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(17): 971-792988.
Citation: Wang Cui-wei, Liu Qingtao. Observation on the Effect of Routine Radiotherapy Combining with the Stereotatic Radiotherapy in Treatment of Squamous Cell Cancer of Lung[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(17): 971-792988.

肺鳞癌常规分割配合立体定向放射治疗疗效观察

Observation on the Effect of Routine Radiotherapy Combining with the Stereotatic Radiotherapy in Treatment of Squamous Cell Cancer of Lung

  • 摘要: 目的:观察常规分割放射治疗配合立体定向放射治疗肺鳞癌的疗效和放射反应.方法:30例肺鳞癌患者采用常规分割放射治疗DT42~44Gy后,给予残存肿瘤灶立体定向放射治疗,5~9Gy/次,隔日1次,肿瘤灶总剂量DT25~36Gy.与同期常规分割放射治疗肺鳞癌患者30例进行对照.结果:常规分割加立体定向放射治疗组与常规分割放射治疗组的有效率及1年生存率分别为86.7%、86.7%及60.0%、53.3%,两组比较有显著性差异(P<0.05).2个组放射性食管炎和放射性肺炎、肺纤维化均无差异(P>0.05).结论:常规分割放射治疗配合立体定向放射治疗肺鳞癌,患者近期疗效和1年生存率优于常规分割放射治疗,有望获得较好疗效.

     

    Abstract: Objective: To observe the effect and side-effect of the treatment of routine radiotherapy combining stereotactic radiotherapy (RRT+SRT) on lung squamous cell cancer. Methods: Thirty patients with lung squamous cell cancer were treated with stereotactic tadiotherapy, DT 42~44Gy, then the residual fows were boosted with stereotactic radiotherapy, which was given by 5~9Gy/fraction,tertian irradiation, DT 25~36Gy. In the same time, another 30 patients with lung squamous cell cancer accepting routine radiotherapy only (RRT) belonged to control group. Results: The effect rate and 1 -year survival rate of RRT+SRT group and RRT group were 86.7%, 86.7%, and 60.0%, 53.3%, respectively. There was significant difference in the two groups (5<0.005), but acute radiation -induced esophagitis and pneumonitis and pulmonary fibrosis didn't have significant difference (5>0.05). Conclusions: Recent effect and 1 -year survival rate of patients with lung squamous cell cancer accepting RRT+SRT is better than that of patients accepting RRT only. So lung squamous cell cancer treated by RRT +SRT may be expected to obtain better effect.

     

/

返回文章
返回